Clinical Development Statistical Strategy
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.

We translate the protocol into statistical instructions clear enough to programme, review and interpret study results. Work can cover an initial document or justified, traceable updates.
This service authors the document. Risk Review evaluates an existing draft and prioritises findings; the two can be sequenced with defined reviewers and responsibilities.
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.
Statistical study design, sample size and power analysis for biomedical research, with documented scenarios, simulation, sampling and randomisation planning.
Data and assumption assessment for trial feasibility: eligibility, populations, follow-up and enrolment scenarios subject to validation.
Tell us about the objective, study stage and deadline. We review the need and availability; we then define the scope with you and prepare a proposal with deliverables, timing and fees.
Do not email patient, clinical or confidential study data. Access and the working environment are agreed before materials are shared.
Discuss your project